Bitwise Ethereum ETF Common shares of beneficial interest (ARCA: ETHW)

Últimas noticias sobre Bitwise Ethereum ETF Common shares of beneficial interest (ARCA:ETHW)

The Funds principal investment strategy is to invest directly in ether (ETH). The fund enables investors to gain exposure to the price movement of ether through a traditional investment vehicle while seeking to minimize administrative costs. The Funds ether is held with one of the worlds leading crypto asset custodians.

Bitwise Ethereum ETF

$ETH

ETHA

ETHE

ETHW

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

Las salidas de Ethereum (CRYPTO: ETH) de Grayscale han experimentado una caída del 80%, lo que podría indicar la llegada de un rally.

Grayscale reduce salidas de Ethereum y podría impulsar un rally

Bitwise Ethereum ETF Common shares of beneficial interest

EthereumPoW - United States Dollar

<p>Raymond James  analyst Patrick Tyler Brown   maintains Construction Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROAD#NASDAQ">ROAD</a>) with a Strong Buy and lowers the price target from $104 to $100.</p>


News

Price Target

Analyst Ratings

ROAD

Raymond James Maintains Strong Buy on Construction Partners, Lowers Price Target to $100

<p>Kinross Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) has outperformed the market over the past 5 years by 2.13% on an annualized basis producing an average annual return of 16.3%. Currently, Kinross Gold has a market capitalization of $17.94 billion. </p>
<p><strong>Buying $100 In KGC:</strong> If an investor had bought $100 of KGC stock 5 years ago, it would be worth <strong>$213.08</strong> today based on a price of $14.58 for KGC at the time of writing.</p>
<h3>Kinross Gold's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745936112_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

<p><i>FitVine Wine becomes official wine sponsor of Life Time Pickleball, bringing delicious zero-sugar wine to more than 775 courts across the U.S.</i></p>
<p><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fitvinewine.com%2F&amp;esheet=54245288&amp;newsitemid=20250429419535&amp;lan=en-US&amp;anchor=FitVine+Wine&amp;index=1&amp;md5=b149c0cdc8bf94d2d6c142ce9c60a8cf">FitVine Wine</a>, a leading wellness wine brand, and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.lifetime.life%2F&amp;esheet=54245288&amp;newsitemid=20250429419535&amp;lan=en-US&amp;anchor=Life+Time&amp;index=2&amp;md5=dec070fb7e9a8dce6810e8784a7eea26">Life Time</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>), the nation's premier healthy lifestyle brand, today announced an exciting new agreement designed to bring mindful indulgence to Life Time members nationwide. As the official wine sponsor of Life Time Pickleball, FitVine will be integrated into a variety of premium social and wellness experiences in clubs across the country, including select Life Time Pickleball Classic tournaments and Afterglo events.</p>


Fitvine Wine And Life Time Announce New Agreement To Bring Mindful Indulgence To Life Time Members Nationwide

WIIM

RCL stock has given up its prior gain. Royal Caribbean shares were trading higher after the company raised its FY25 adjusted EPS guidance.

<ul>
<li><strong>Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies.</strong></li>
<li><strong>High transgene expression and improved safety profile of Aldveron's Nanoplasmid&#x2122;&nbsp;vector technology and the gentle gene-delivery of Kytopen's Flowfect Tx&#x2122; platform with unlimited scale, together offer enhanced CRISPR-mediated T-cell engineering resulting in high yields.</strong></li>
<li><strong>A poster summarizing the data will be presented at ISCT, May 7-10, 2025, in New Orleans.</strong></li>
</ul>
<p>CAMBRIDGE, Mass. and FARGO, N.D., April 29, 2025 /PRNewswire/ --&nbsp;Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene editing, mRNA vaccine and therapeutics, viral gene therapy, and modified gene therapy spaces; today announced,&nbsp;a joint marketing agreement aimed at enhancing the workflow solutions for cell therapy manufacturers. The collaboration will focus on the joint promotion of the synergies achieved by combining the Aldveron Nanoplasmid&#x2122; vector technology with Kytopen's Flowfect Tx&#x2122; GMP cellular engineering platform in CRISPR-mediated engineering of primary T Cells.</p>


Kytopen And Aldevron Announce Joint Marketing Agreement To Enhance Workflow Solutions For Cell Therapy Manufacturers

<p>Raymond James  analyst Savanthi Syth   reiterates Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) with a Outperform and lowers the price target from $42 to $40.</p>


Reiteration

Raymond James Reiterates Outperform on Southwest Airlines, Lowers Price Target to $40

<p>Eagle Bancorp Montana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBMT#NASDAQ">EBMT</a>) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.32 by 28.12 percent. This is a 70.83 percent increase over earnings of $0.24 per share from the same period last year.  The company reported quarterly sales of $20.92 million which beat the analyst consensus estimate of $16.64 million by 25.74 percent.  This is a 37.49 percent increase over sales of $15.21 million the same period last year.</p>


Earnings

Earnings Beats

EBMT

Eagle Bancorp Montana Q1 EPS $0.41 Beats $0.32 Estimate, Sales $20.92M Beat $16.64M Estimate

<p>Raymond James  analyst Ric Prentiss   reiterates SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Strong Buy and raises the price target from $265 to $268.</p>


SBAC

Raymond James Reiterates Strong Buy on SBA Communications, Raises Price Target to $268

<p><a href="https://www.paloaltonetworks.com/content/pan/en_US/company/press/2025/at-t-joins-forces-with-palo-alto-networks-to-introduce-secure-connectivity-solution-for-business-customers.html">https://www.paloaltonetworks.com/content/pan/en_US/company/press/2025/at-t-joins-forces-with-palo-alto-networks-to-introduce-secure-connectivity-solution-for-business-customers.html</a></p>


General

PANW

AT&T Joins Forces with Palo Alto Networks to Introduce Secure Connectivity Solution for Business Customers

<p>Raymond James  analyst Andrew Cooper   reiterates Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) with a Outperform and lowers the price target from $145 to $120.</p>


RVTY

Raymond James Reiterates Outperform on Revvity, Lowers Price Target to $120

Biotech

AFMD

Affimed Demonstrates Increased AFM24 Exposure Correlates With Improved Response Rates And Progression-Free Survival In Refractory NSCLC Patients At AACR Annual Meeting

<p><strong>Corning Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) shares are trading higher after the company <a href="https://www.benzinga.com/pressreleases/25/04/b45062667/corning-announces-strong-first-quarter-2025-financial-results-1-and-reiterates-confidence-in-sprin" target="_blank" rel="noreferrer noopener">reported first-quarter 2025 results</a>.</p>
<p>Core sales grew&nbsp;13%&nbsp;year-on-year (Y/Y) to&nbsp;$3.68 billion, beating the&nbsp;analyst <a href="https://www.benzinga.com/earnings">consensus estimate of&nbsp;$3.64 billion</a>.&nbsp;</p>
<p>The <strong>Apple</strong> glass supplier's core EPS of 54 cents beat the analyst consensus estimate of 51 cents.</p>
<p><strong><em>Also Read:</em></strong><em> <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45039357/apples-india-game-plan-looks-smarter-as-tariff-heat-rises-analyst-highlights-4-stocks-that-could-benefit" rel="noreferrer noopener">Apple&#8217;s India Game Plan Looks Smarter As Tariff Heat Rises &#8211; Analyst Highlights 4 Stocks That Could Benefit</a></em></p>
<p>As of January 1, 2025, Honeywell reorganized its business segments, moving the Automotive Glass Solutions business from the Hemlock and Emerging Growth Businesses into the newly formed Automotive segment, where it is now managed alongside Environmental Technologies.</p>
<p>Display Technologies' sales grew by&nbsp;4% Y/Y&nbsp;to&nbsp;$905&nbsp;million.&nbsp;Optical Communications sales increased by&nbsp;46% Y/Y&nbsp;to&nbsp;$1.355 billion,&nbsp;led by continued strong adoption of Corning's new Gen AI products.</p>
<p>In Optical Communications, Enterprise business sales rose 106% Y/Y, led by strong demand for the new Gen AI products.</p>
<p>Specialty Materials sales rose&nbsp;10% Y/Y&nbsp;to&nbsp;$501&nbsp;million in the quarter. Life Sciences sales fell&nbsp;1% Y/Y&nbsp;to&nbsp;$234 million.</p>
<p>Hemlock and Emerging Growth Businesses sales decreased&nbsp;11% Y/Y to&nbsp;$244 million in the quarter.</p>
<p>The core gross margin was&nbsp;37.9% in the quarter, an improvement of 110-basis-point year-over-year.</p>
<p><strong>Outlook</strong>: In the second quarter, the company expects to grow core sales to around $3.85 billion (vs. <span style="box-sizing: border-box; margin: 0px; padding: 0px;">the consensus of $3.82 billion) and increase core EPS significantly faster than sales, in a range of $0.55-$0.59<a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noopener"> (vs. the </a></span><a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">street view of $0.56)</a>.</p>
<p>The guidance reflects the impact of currently enacted tariffs of around $0.01-$0.02, along with a $0.03 temporary increase in cost to meet increased demand for Gen AI and solar products.</p>
<p><strong>Wendell P. Weeks</strong>, chairman and chief executive officer, said,&nbsp;&#8220;We remain confident in our ability to deliver our&nbsp;Springboard plan. We&#8217;re well positioned to maintain momentum despite a dynamic external environment because our growth is underpinned by powerful secular trends that are underway today.&#8221;</p>
<p>Investors can gain exposure to GLW via <strong>ProShares Smart Materials ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINT#NYSE">TINT</a>) and Professionally Managed Portfolios Otter Creek Focus Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFS#NYSE">OCFS</a>).</p>
<p><strong>Price Action:</strong> GLW shares were up 1.70% at $44.85 premarket at the last check Tuesday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com//node/44950358" target="_blank" rel="noreferrer noopener">Amphenol Q1 Earnings: 48% Topline Growth, Driven By IT, Mobile, Defense Sectors</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Equities

Large Cap

Guidance

Movers

Professionally Managed Portfolios Otter Creek Focus Strategy ETF

OCFS

TINT

Gen AI Demand Ignites Corning Q1 Optical Communications Sales, Sees Continued Growth In Q2 Despite Tariff Woes

<p>Raymond James  analyst Daniel Tamayo   reiterates Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) with a Outperform and lowers the price target from $45 to $41.</p>


MBIN

Raymond James Reiterates Outperform on Merchants Bancorp, Lowers Price Target to $41

<p><a href="https://www.reuters.com/business/energy/china-waives-tariffs-us-ethane-imports-sources-say-2025-04-29/">https://www.reuters.com/business/energy/china-waives-tariffs-us-ethane-imports-sources-say-2025-04-29/</a></p>


'China waives tariffs on US ethane imports, sources say'- Reuters

<p>Raymond James  analyst Buck Horne   maintains M/I Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHO#NYSE">MHO</a>) with a Strong Buy and lowers the price target from $168 to $140.</p>


Raymond James Maintains Strong Buy on M/I Homes, Lowers Price Target to $140

<p>Wells Fargo  analyst Eva Fortea Verdejo   maintains ITeos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) with a Overweight and lowers the price target from $17 to $16.</p>


ITOS

Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $16

<p>International Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) is preparing to release its quarterly earnings on Wednesday, 2025-04-30. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect International Paper to report an <strong>earnings per share</strong> (EPS) of $0.37.</p>
<p>The announcement from International Paper is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS missed by $0.07, leading to a 2.49% drop in the share price on the subsequent day.</p>
<p>Here's a look at International Paper's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.05</td>
<td>0.26</td>
<td>0.41</td>
<td>0.22</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>0.44</td>
<td>0.55</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>0.0%</td>
<td>-0.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935398_0.png" alt="eps graph" /></p>
<h3>Performance of International Paper Shares</h3>
<p>Shares of International Paper were trading at $47.48 as of April 28. Over the last 52-week period, shares are up 34.91%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on International Paper</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding International Paper.</p>
<p>Analysts have provided International Paper with 7 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $59.29, suggesting a potential 24.87% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Avery Dennison, Graphic Packaging Holding and Sonoco Prods, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Avery Dennison, with an average 1-year price target of $202.54, suggesting a potential 326.58% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Graphic Packaging Holding, with an average 1-year price target of $30.0, suggesting a potential 36.82% downside.</li>
<li>Analysts currently favor an Buy trajectory for Sonoco Prods, with an average 1-year price target of $54.8, suggesting a potential 15.42% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Avery Dennison, Graphic Packaging Holding and Sonoco Prods are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>International Paper</td>
<td>Buy</td>
<td>-0.46%</td>
<td>$1.33B</td>
<td>-1.75%</td>
</tr>
<tr>
<td>Avery Dennison</td>
<td>Outperform</td>
<td>-1.71%</td>
<td>$609.20M</td>
<td>7.42%</td>
</tr>
<tr>
<td>Graphic Packaging Holding</td>
<td>Neutral</td>
<td>-6.85%</td>
<td>$453M</td>
<td>4.58%</td>
</tr>
<tr>
<td>Sonoco Prods</td>
<td>Buy</td>
<td>24.51%</td>
<td>$85.59M</td>
<td>-1.81%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>International Paper ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, it is at the bottom.</p>
<h3>Unveiling the Story Behind International Paper</h3>
<p>International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one third of the North American corrugated packaging market. Though it has operations in Brazil, India, and China, more than three fourths of its sales come from North America. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.</p>
<h3>Key Indicators: International Paper's Financial Health</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Negative Revenue Trend:</strong> Examining International Paper's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-0.46%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> International Paper's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-3.21%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> International Paper's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-1.75%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> International Paper's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-0.64%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.72</strong>, International Paper adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/IP/earnings"><strong>To track all earnings releases for International Paper visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Preview Of International Paper's Earnings

<p>Tenaris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TS#NYSE">TS</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-30. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Tenaris will report an <strong>earnings per share</strong> (EPS) of $0.77.</p>
<p>Investors in Tenaris are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.23 in the last quarter, leading to a 0.69% drop in the share price on the following day.</p>
<p>Here's a look at Tenaris's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.71</td>
<td>0.66</td>
<td>0.97</td>
<td>1.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.94</td>
<td>0.81</td>
<td>0.59</td>
<td>1.27</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>2.0%</td>
<td>-10.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935378_0.png" alt="eps graph" /></p>
<h3>Tracking Tenaris's Stock Performance</h3>
<p>Shares of Tenaris were trading at $33.75 as of April 28. Over the last 52-week period, shares are up 0.78%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on Tenaris</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Tenaris.</p>
<p>Analysts have provided Tenaris with 4 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $46.0, suggesting a potential 36.3% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of TechnipFMC, NOV and Archrock, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for TechnipFMC, with an average 1-year price target of $40.0, suggesting a potential 18.52% upside.</li>
<li>Analysts currently favor an Outperform trajectory for NOV, with an average 1-year price target of $18.62, suggesting a potential 44.83% downside.</li>
<li>Analysts currently favor an Buy trajectory for Archrock, with an average 1-year price target of $33.0, suggesting a potential 2.22% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for TechnipFMC, NOV and Archrock are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Halliburton</td>
<td>Neutral</td>
<td>-6.67%</td>
<td>$879M</td>
<td>1.95%</td>
</tr>
<tr>
<td>TechnipFMC</td>
<td>Outperform</td>
<td>9.38%</td>
<td>$464.90M</td>
<td>4.61%</td>
</tr>
<tr>
<td>NOV</td>
<td>Outperform</td>
<td>-1.49%</td>
<td>$493M</td>
<td>2.49%</td>
</tr>
<tr>
<td>Archrock</td>
<td>Buy</td>
<td>25.74%</td>
<td>$151.17M</td>
<td>4.52%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Tenaris ranks at the top for Revenue Growth with a positive 9.38%, outperforming its peers. It also leads in Gross Profit with $464.90M. However, it ranks lower in Return on Equity at 4.61%, compared to the highest performer at 4.52%. Overall, Tenaris is positioned favorably among its peers based on these key metrics.</p>
<h3>Get to Know Tenaris Better</h3>
<p>Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the US, Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.</p>
<h3>Tenaris's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Tenaris faced challenges, resulting in a decline of approximately <strong>-16.68%</strong> in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Tenaris's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>18.14%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Tenaris's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>3.06%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.48%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.04</strong>.</p>
<p><a href="https://www.benzinga.com/quote/TS/earnings"><strong>To track all earnings releases for Tenaris visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Tenaris's Earnings Preview

<p><strong>Crown Castle</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Crown Castle will report an <strong>earnings per share</strong> (EPS) of $1.02. </p>
<p>Investors in Crown Castle are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.01, leading to a 10.37% increase in the share price the following trading session.</p>
<p>Here's a look at Crown Castle's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.81</td>
<td>1.80</td>
<td>1.65</td>
<td>1.71</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.80</td>
<td>1.84</td>
<td>1.62</td>
<td>1.72</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>10.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935368_0.png" alt="eps graph" /></p>
<h3>Market Performance of Crown Castle's Stock</h3>
<p>Shares of Crown Castle were trading at $100.92 as of April 28. Over the last 52-week period, shares are up 8.96%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/CCI/earnings"><strong>To track all earnings releases for Crown Castle visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look Ahead: Crown Castle's Earnings Forecast

<p>AvalonBay Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-30. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that AvalonBay Communities will report an <strong>earnings per share</strong> (EPS) of $2.80.</p>
<p>AvalonBay Communities bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS missed by $0.03 in the last quarter, leading to a 1.11% drop in the share price on the following day.</p>
<p>Here's a look at AvalonBay Communities's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.83</td>
<td>2.71</td>
<td>2.71</td>
<td>2.65</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.80</td>
<td>2.74</td>
<td>2.77</td>
<td>2.70</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>4.0%</td>
<td>4.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935360_0.png" alt="eps graph" /></p>
<h3>Performance of AvalonBay Communities Shares</h3>
<p>Shares of AvalonBay Communities were trading at $207.8 as of April 28. Over the last 52-week period, shares are up 10.38%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on AvalonBay Communities</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on AvalonBay Communities.</p>
<p>Analysts have given AvalonBay Communities a total of 7 ratings, with the consensus rating being Neutral. The average one-year price target is $233.86, indicating a potential 12.54% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Equity Residential, Mid-America Apartment and Essex Property Trust, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Equity Residential, with an average 1-year price target of $77.67, suggesting a potential 62.62% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Mid-America Apartment, with an average 1-year price target of $170.44, suggesting a potential 17.98% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Essex Property Trust, with an average 1-year price target of $305.6, suggesting a potential 47.06% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Equity Residential, Mid-America Apartment and Essex Property Trust, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>AvalonBay Communities</td>
<td>Neutral</td>
<td>5.09%</td>
<td>$458.90M</td>
<td>2.35%</td>
</tr>
<tr>
<td>Equity Residential</td>
<td>Neutral</td>
<td>5.40%</td>
<td>$489.40M</td>
<td>3.83%</td>
</tr>
<tr>
<td>Mid-America Apartment</td>
<td>Neutral</td>
<td>1.40%</td>
<td>$176.47M</td>
<td>2.78%</td>
</tr>
<tr>
<td>Essex Property Trust</td>
<td>Neutral</td>
<td>7.76%</td>
<td>$65.92M</td>
<td>4.69%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>AvalonBay Communities ranks in the middle for Consensus. It is at the bottom for Revenue Growth. It is at the top for Gross Profit. It is at the bottom for Return on Equity.</p>
<h3>About AvalonBay Communities</h3>
<p>AvalonBay Communities owns a portfolio of 289 apartment communities with over 87,000 units and is developing 17 additional properties with over 6,000 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.</p>
<h3>Key Indicators: AvalonBay Communities's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, AvalonBay Communities showcased positive performance, achieving a revenue growth rate of <strong>5.09%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> AvalonBay Communities's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>37.81%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> AvalonBay Communities's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.35%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> AvalonBay Communities's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.32%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.69</strong>, AvalonBay Communities adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/AVB/earnings"><strong>To track all earnings releases for AvalonBay Communities visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Comments

Bitwise Ethereum ETF Common shares of beneficial interest

Noticias

Últimas noticias sobre Bitwise Ethereum ETF Common shares of beneficial interest (ARCA:ETHW)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL